Almirall, S.a.

Almirall Hermal Gmbh

Christoph Willers

Henning Mallwitz

Manfred Melzer

Carmen Matthies

Fritjof Evers

Klaus Treudler

Ricarda Wessel

Ricarda Meyer

Topical pharmaceutical compositions are described comprising, based on the total weight of the composition: a) 0.01 to 0.2 wt. % of mometasone furoate, b) 5 to 18 wt. % of hexylene glycol, c) 20 to 40 wt. % of water, and d) 25 to 70 wt. % of an oil phase. Said compositions are stable and can be safely and easily applied over large surface areas of the skin in an acceptable way by the general patient population for the treatment or prevention of psoriasis, atopic dermatitis (atopic eczema) and other skin disorders or diseases.

Topical pharmaceutical compositions

The invention relates to a topical gel composition for use in the treatment of actinic keratosis comprising (a) an active agent for treatment of actinic keratosis, (b) a keratolytically active agent, (c) a gel former, and (d) an organic solvent.

Topical composition for the treatment of actinic keratosis

Growing community of inventors

Hamburg, Germany

Christoph Willers